1. Home
  2. ERII vs CRMD Comparison

ERII vs CRMD Comparison

Compare ERII & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energy Recovery Inc.

ERII

Energy Recovery Inc.

HOLD

Current Price

$11.29

Market Cap

586.9M

Sector

Technology

ML Signal

HOLD

Logo CorMedix Inc.

CRMD

CorMedix Inc.

HOLD

Current Price

$7.29

Market Cap

509.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ERII
CRMD
Founded
1992
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
586.9M
509.9M
IPO Year
2008
2009

Fundamental Metrics

Financial Performance
Metric
ERII
CRMD
Price
$11.29
$7.29
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$17.07
$15.20
AVG Volume (30 Days)
717.2K
1.1M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
5.00
780.00
EPS
0.42
2.04
Revenue
$134,987,000.00
$311,709,000.00
Revenue This Year
N/A
$0.30
Revenue Next Year
$20.55
N/A
P/E Ratio
$27.15
$3.59
Revenue Growth
N/A
617.03
52 Week Low
$9.35
$6.13
52 Week High
$18.31
$17.43

Technical Indicators

Market Signals
Indicator
ERII
CRMD
Relative Strength Index (RSI) 56.75 59.93
Support Level $9.47 $6.14
Resistance Level $11.61 $7.44
Average True Range (ATR) 0.33 0.24
MACD 0.29 0.10
Stochastic Oscillator 88.14 81.08

Price Performance

Historical Comparison
ERII
CRMD

About ERII Energy Recovery Inc.

Energy Recovery Inc designs and manufactures energy-saving technologies. The firm uses its proprietary pressure exchanger technology to help customers in multiple industries improve their operations and lower their emissions. Using its proprietary technology, it offers energy recovery devices, including pressure exchangers, pumps, and turbochargers, mainly used for seawater desalination and wastewater treatment. Additionally, the company is involved in the development of emerging technologies, such as the PX G1300 used in industrial and commercial refrigeration applications. The firm's reportable operating segments are: Water, which generates maximum revenue, and Emerging Technologies. Geographically, it generates maximum revenue from the Middle East, and the rest from other markets.

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Share on Social Networks: